VC-backed ReViral appoints CEO [Reuters]
DOVA PHARMACEUTICALS (DOVA)
Last dova pharmaceuticals earnings: 11/12 06:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dova.com/investor-relations
Company Research
Source: Reuters
VC-backed ReViral appoints CEO ReViral Ltd Alex C. Sapir Dova Pharmaceutical New Leaf Venture Partners, Novo Ventures, Perceptive Advisors, Andera Partners, OrbiMed Brace Pharma Capital. PRESS RELEASE LONDON–(BINESS WIRE)–ReViral Ltd., a clinical-stage company focused on developing novel, antiviral compounds that target respiratory syncytial virus (RSV), today announced that Alex C. Sapir has been appointed Chief Executive Officer (CEO) and elected to the Board of Directors, effective June 10, 2019. Mr. Sapir succeeds Dr. Eddy Littler, who will serve as Chief Operating Officer (COO). “Today, ReViral has a rich pipeline of wholly-owned RSV antiviral product candidates and strong research,” said Dr. Kenneth Powell, Chairman of the Board. “Alex’s proven leadership skills combined with his deep experience building biotech businesses make him ideally suited to take ReViral to the next level. On behalf of the Board of Directors, I’d also like to thank Eddy for his successful time at ReViral
Show less
Read more
Impact Snapshot
Event Time:
DOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOVA alerts
High impacting DOVA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics